The Braves enter the series finale against the Mets with one goal left on the table: avoid the sweep.
Atlanta won’t get the series victory, but there is still a chance to leave with something after a stretch that has been defined by uneven offense and a bullpen that has already done enough damage. The lineup card brings a few changes, and the most notable one is Drake Baldwin leading off. That moves Ronald Acuña Jr. into the second spot, giving the Braves a different look at the top.
There’s also some added hope in the middle and lower parts of the order. Jim Jarvis and Mike Yastrzemski are both in the lineup, and the Braves are counting on them to provide some extra punch. If Matt Olson can add another bomb, that would only help Atlanta’s chances of finally putting together enough run support.
That’s been the issue for the Braves: too many nights where the offense never really gets going, especially in a Chris Sale start. The inconsistency has been a major reason Atlanta keeps falling behind.
On the other side, Christian Scott gets the ball for the Mets. He comes in with a 3.13 ERA, and this one shapes up as a solid matchup on the mound. New York is coming off a low-scoring win and will try to finish the series the same way it started.
The bigger question is simple. Both lineups have flashed enough to suggest they can produce, but neither has been steady for long. Tonight, one of them has to turn that brief spark into a full game.
In Other News...
Braves May Be Near A Tough Austin Riley Decision
Austin Rileys recent stretch has only sharpened the questions around his spot in the Braves everyday mix. The offense has been quiet enough to notice, with multiple hitless games and plenty of strikeouts piling up, and the numbers from the Orioles series did little to ease the concern. For a player whose bat has long been the bigger draw than his glove, that kind of dip lands hard in Atlanta.
Rileys defense at third base has also remained part of the conversation, because the underlying evaluation there has never really moved far in his favor. The Braves are now weighing how to handle all of it as the season moves on, and the real issue is less about one bad week than whether this is the point where a longer look at his role becomes unavoidable. [Read more 🡒]
Braves Top Prospect Is Suddenly Demanding Everyone's Attention
Conor Essenburg is making a very loud case for attention in the Braves system, and the timing could hardly be better for a player who only recently worked his way back from an oblique injury. The Single-A Augusta GreenJackets prospect has been on a serious tear since returning in late May, and his latest stretch has only strengthened the sense that his bat is starting to separate from the rest of the league.
Essenburg now has six home runs in his last five minor league games and is up to 14 homers in 56 Single-A contests, with a .278 average to go with it. For Atlanta, the question is no longer whether the power is real, but how quickly he keeps forcing the organization to think about the next level. [Read more 🡒]
Braves Face A Painful Decision On Three Familiar Names
The Braves front office is staring at a familiar kind of roster puzzle, one that mixes short-term need with long-term caution. Sean Murphy, Ha-Seong Kim and Spencer Strider all come with different levels of value, risk and contract baggage, which is why any conversation about moving one of them is more complicated than a simple buy-or-sell decision. Murphys defense still matters, and the club has little incentive to rush into dealing a player whose value has been dulled by recent injuries and inconsistency.
Kims situation adds another layer of pressure because his rehab clock is winding down, forcing Atlanta to decide whether to keep trying to fit him back in or move on in some form. A trade would not bring much back beyond salary relief, while the alternatives each carry their own downside for a team trying to manage both the present roster and the books. Strider, meanwhile, is a reminder that even the most recognizable names can become difficult to place in a market when health and contract status cloud the picture. [Read more 🡒]